Innovators Archive - WISH

Philippe Ganz

wish admin — Mon, 25 Mar 2024 09:19:53 +0000

aiEndoscopic revolutionizes modern endoscopy. It combines artificial intelligence with robotics to enable assistive or even autonomous endoscopy. aiEndoscopic aims for the best patient outcomes and treatment success, independent of human performance & skills. The company is a spin-off from a university project held between three prominent universities in Zürich: ETH Zürich, Universität Zürich, and Universitätsspital Zürich. The company’s first innovation is called intuBot, it is an assistive device that operates at the level of airway management, and allows for easier and safer tracheal intubations. Tracheal intubation is a life-saving process that requires extensive training. intuBot is the first device to actively support the practitioner in this skill-based task, allowing less experienced practitioners to intubate successfully and save lives. intuBot has an intelligent system that uses AI to navigate itself using the surrounding anatomy and maneuver accordingly into the trachea. Currently, aiEndoscopic is working to apply this digital health technology in other prominent endoscopic procedures, e.g., bronchoscopy, colonoscopy, or laparoscopy. This AI solution will not only simplify those complex procedures but also improve the outcome and reduce the costs of the treatment.

The post Philippe Ganz appeared first on WISH.

Samir Abou Fakhir & Mohammad Ibrahim

wish admin — Mon, 25 Mar 2024 09:19:06 +0000

GLOVI was invented as a solution to a very sensitive and critical problem that is faced by hospitals and surgeons worldwide; hospital-acquired infections. Thousands of people die following HAIs caused by medical errors that originate from bacterial and viral contamination and transmission to the patient. This device will be responsible for unpacking the surgical gloves from their packaging without any human interference. This process will take place with the help of laser technology. The GLOVI machine will support the medical staff performing this duty to help them prevent using infected gloves and to facilitate the overall process.

The post Samir Abou Fakhir & Mohammad Ibrahim appeared first on WISH.

Loulia Kasem

wish admin — Mon, 25 Mar 2024 09:18:34 +0000

Preterm birth is defined as giving birth before 37 weeks of pregnancy. 10% of pregnant women worldwide give birth prematurely and half of them have no risk factors or early labor symptoms. Premature babies born without preventive medical procedures have higher chances of neonatal morbidity and mortality. In fact, preterm birth is the number one cause of death for children under the age of five. Today, to test for preterm labor, doctors perform invasive procedures in the hospital. The lack of remote monitoring tools for preterm birth makes it impossible for doctors to identify, early on, all their patients at risk of preterm birth. The only solution to address this problem is to provide pregnant women with a self-test. Rea Diagnostics is a spin-off of the Swiss Federal Institute of Technology in Lausanne, Switzerland, that is developing diagnostic technology for women’s healthcare. The company’s first product is a self-test that identifies clinically proven biomarkers of preterm labor in vaginal discharge. A negative test result excludes the risk of childbirth within the next seven days, while a positive test result indicates a high risk of childbirth. The self-test allows pregnant women to detect any risk of preterm birth and gives doctors the chance to better design an antenatal management plan.

The post Loulia Kasem appeared first on WISH.

Nicolas Vachicouras

wish admin — Mon, 25 Mar 2024 09:17:58 +0000

Neurosoft Bioelectronics is a neurotechnology start-up based in Switzerland, developing and manufacturing implantable electrodes that can be used to record or stimulate the surface of the brain to monitor or treat severe neurological disorders. Neurosoft has introduced a new class of soft, stretchable, and high-density implantable electrodes that seamlessly interface with the brain, promoting long-term bio-integration of the devices in the body, reducing surgical and implantation risks and improving recording and stimulation precision. With its soft electrodes, the company aims to treat severe tinnitus, identified as the main indication for the platform’s technology. Severe tinnitus is a debilitating disorder characterized by a permanent and loud ringing in the ears. It impacts 50 million people worldwide, of which 7% attempt to commit suicide every year. Unfortunately, there is no treatment for tinnitus. Neurosoft Bioelectronics is working to solve the root cause of the disorder with the first implantable brain-computer interface to suppress tinnitus through closed-loop cortical electrical stimulation. The company’s breakthrough soft electrodes are the only ones that can allow safe and optimal surgical access to the brain target, located at the bottom of a large brain sulcus. Neurosoft Bioelectronics’ market size in Europe and USA is estimated to $3B.

The post Nicolas Vachicouras appeared first on WISH.

Batuhan Ergör Ömer Akça

wish admin — Mon, 25 Mar 2024 09:17:18 +0000

ERG Controls digitizes hand hygiene monitoring to minimize hospital-acquired infections. With its AI-powered IoT system, YIKA, the company brings WHO’s standards everywhere. Its goal is to turn YIKA into the global standard controller of hand hygiene compliance. Hospitals are required to monitor their personnel’s hands hygiene. However, this is mostly done manually through observation. This type of monitoring is limited, expensive, and can yield misleading statistics resulting in major inadequacies. In fact, according to the Centers of Disease Control and Prevention, less than 50% of hospitals worldwide comply with the hand hygiene standards of the WHO. In other words, according to CDC and the WHO, healthcare professionals wash their hands half of the time they are supposed to in hospitals. Lack of hand hygiene is the leading cause of hospital infections. This leads to hundreds and thousands of people losing their lives and billions of dollars of direct losses. According to the WHO, these numbers can be reduced by half if healthcare professionals comply to hand hygiene standards. YIKA is an end-to-end IoT system that monitors all hand hygiene activity. YIKA was designed for healthcare professionals working in hospitals. It uses smart badges, sensors, and AI-powered handwashing modules and reports the personnel’s compliance rate to WHO’s 5 Hand Hygiene Moments via its web dashboard. The compliance rate is measured on an individual or shift or profession basis.

The post Batuhan Ergör Ömer Akça appeared first on WISH.

Dario Dilernia

wish admin — Mon, 25 Mar 2024 09:15:58 +0000

“Sequegenics” is implementing a new approach that dramatically reduces the cost of sequencing a human genome with long-read next generation sequencing technology. As a result, the company is changing the economics of long-read technology, turning it into a sustainable business. 400 million people around the world are diagnosed with rare genetic disorders and need to have their genomes sequenced. Long-read is the only available technology capable of detecting the pathogenic variant causing their disease. “Sequegenics” is working to establish itself as the first company to exclusively use long-read genome sequencing technologies. This will not only help advance the diagnosis of rare diseases but will also allow the company to become the technological liaison between patients, lacking accurate diagnosis, and the pharmaceutical and biotech industry developing new treatments for them.

The post Dario Dilernia appeared first on WISH.

José Expósito Ollero

wish admin — Mon, 25 Mar 2024 09:15:36 +0000

NELA BioDynamics is a spin-off from a cooperation between the Polytechnic University of Valencia and INCLIVA, a healthcare research institute based in Spain. Its mission is to provide innovative technological solutions, aimed to improve the patient’s quality of life and the sustainability of healthcare systems at the level of orthopedic surgery. By 2050, 130M people are expected to suffer from osteoarthritis, of which 40M will need joint replacements. Changes in lifestyle are an added risk factor to other population strata. These changes are estimated to affect 20-33% of the world’s population. Even though they are very traumatic and imprecise, techniques used today haven’t changed in 40 years, causing many problems that can be solved. NELA presents a disruptive implant. Its patented technology eliminates the need to fix the stem by hammering rasps or using bone cement. The surgical technique developed reduces the surgical time in half and the post-operative time to a few hours. It also reduces the cost of the process by transforming joint replacement into an outpatient procedure. Furthermore, the surgeon can precisely control the amount of fixation according to the patient’s bone quality, allowing a customized treatment. Critical testing has been carried out, confirming the advantages of this implant. Currently, NELA BioDynamics is launching a pre-series A round to finish pre-clinical testing and start clinical trials in 2023.

The post José Expósito Ollero appeared first on WISH.

Rain Aalberg

wish admin — Mon, 25 Mar 2024 09:15:04 +0000

Respiray Wear A+ defeats allergies with just one click. This innovation is a game changer for millions of people who have pet dander, pollen, dust, and mold allergies. Airborne allergies can affect one’s everyday life. Sneezing and suffering from watery eyes or an itchy nose is never pleasant. Respiray Wear A+ introduces an innovative solution to this problem. It is a wearable device that filters the air a person inhales to make it allergen-free. Unlike air purifiers, Respiray Wear A+ is designed for convenience and direct, effective protection against allergies — anywhere one might go. Respiray Wear A+ provides full protection in any indoor space where one may be exposed to airborne allergens: when visiting friends or family who have pets, during the pollen season, in dusty or moldy places, and more. Super-Effective Allergy Reduction Lab tests have shown that, through its user-replaceable filters, Respiray Wear A+ effectively reduces airborne allergen particles by more than 99%. Wearable and Easy-to-Use The wearability of Respiray Wear A+ ensures direct and effective protection in any indoor space. It is also rechargeable and user-friendly. Lightweight and Stylish In addition to its practicality, Respiray Wear A+ is lightweight and small. Its simple design makes it a cool accessory to wear as well.

The post Rain Aalberg appeared first on WISH.

Shubhendra Singh Thakur

wish admin — Mon, 25 Mar 2024 09:13:01 +0000

ERLYSIGN is a biotechnology startup working on developing the next generation of early stage prognostics and diagnostics solutions allowing an early stage detection of multiple types of cancer. ERLYSIGN uses human saliva to detect the presence of precancerous cells in a noninvasive and painless manner. The active detection method checks for protein biomarkers and mRNAs and can detect the presence of cancerous cells even before a visible tumor or lesion appears. ERLYSIGN’s first test kit detects oral cancer through saliva samples. It is both quick and easy to use. The test was validated by the experts of The American Oncology Institute, HCG, and US based Oncologists. It allows the detection of precancerous conditions even before a visible tumor or lesion appears in the oral cavity, lip, tongue, or throat. At this stage, ERLYSIGN’s test kit is a patented product under large scale clinical trials in collaboration with HCG, Southeast Asia’s largest cancer care network. ERLYSIGN is currently working on developing early detection kits for lung, breast, and pancreatic cancer as well. Founder:

The post Shubhendra Singh Thakur appeared first on WISH.

Mohammed Tahri-Sqalli

wish admin — Mon, 25 Mar 2024 09:10:19 +0000

eyeTech provides medical professionals with a revolutionary electrocardiogram (ECG) training platform. The platform uses AI and eye-tracking capabilities to customize an adaptive and reactive training program verified by expert cardiology consultants. eyeTech allows med students to become decent ECG interpreters in 2 years instead of 5. This solution is considered unique because it bridges ECG training in a single platform. eyeTech believes that inaccurate ECG diagnosis is due to a lack of efficient and innovative training, prolonged periods of training, and evolving heart arrhythmias. All these factors put together prevent medical practitioners from reaching an accurate ECG diagnosis, a faster medical intervention time, and ultimately, a patient-centered care. Founders: Mohammed Tahri-Sqalli Shokhrukhbek Nurmatov Mukhammadjon Gafurov

The post Mohammed Tahri-Sqalli appeared first on WISH.